Bold Therapeutics Revenue

Biotechnology Research • 850 W Hastings St, Suite 515, Canada • 11-20 Employees

Bold Therapeutics revenue & valuation

Annual revenue	$1,711,100
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$5,500,000
Total funding	$796,600

Key Contacts at Bold Therapeutics

Kevin Vos

Director, Pipeline Management

Hooshmand Sheshbaradaran

Member Board Of Directors

Don Mccaughey

Member Board Of Directors

Alun Rees

Senior Director Cmc

Mark Bazett

Senior Director Of Preclinical Development

Company overview

Headquarters	850 W Hastings St, Suite 515, Vancouver, British Columbia V6C 3N9, CA
Phone number	+16042629899
Website	bold-therapeutics.com
NAICS	541714
SIC	873
Founded	2018
Employees	11-20
Socials

Bold Therapeutics Email Formats

Bold Therapeutics uses 1 email format. The most common is {2char} (e.g., {2char}@bold-therapeutics.com), used 100% of the time.

Format	Example	Percentage
{2char}	{2char}@bold-therapeutics.com	100%

About Bold Therapeutics

Bold Therapeutics is the world leader in the development of novel metallotherapeutics. Bold Therapeutics' lead program, BOLD-100, has demonstrated positive safety and efficacy in Phase 2 clinical trials in colorectal, biliary tract and gastric cancers, with presentations at ASCO 2024 and ASCO GI 2024. Bold Therapeutics expects to initiate pivotal Phase 3 trials in the near future.

Employees by Management Level

Total employees: 11-20

Seniority

Employees

Director

Entry

Senior

Employees by Department

Bold Therapeutics has 7 employees across 3 departments.

Departments

Number of employees

Funding Data

Explore Bold Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2021-07-09	9	$796,600

Funding Insights

$796,600

Total funding amount

$796,600

Most recent funding amount

Number of funding rounds

Bold Therapeutics Tech Stack

Discover the technologies and tools that power Bold Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Cloudflare

CDN

Google Workspace

Cloudflare Rocket Loader

Performance

jQuery

JavaScript libraries

HTTP/3

Miscellaneous

fullPage.js

JavaScript libraries

PHP

Programming languages

Font Awesome

Font scripts

Highlight.js

JavaScript libraries

PWA

Miscellaneous

lit-element

JavaScript libraries

Bootstrap

UI frameworks

Frequently asked questions

Bold Therapeutics is located in 850 W Hastings St, Suite 515, CA.

You can reach Bold Therapeutics at +16042629899.

Bold Therapeutics generates an estimated annual revenue of $1,711,100. This revenue figure reflects the company's market position and business performance in its industry.

Bold Therapeutics has an estimated valuation of $5,500,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Bold Therapeutics was founded in 2018, making it 8 years old. The company has established itself as a significant player in its industry over this time.

Bold Therapeutics has approximately 11-20 employees. The company continues to grow its workforce to support its business operations and expansion.

Bold Therapeutics has raised a total of $796,600 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at Bold Therapeutics

Kevin Vos

Director, Pipeline Management

Hooshmand Sheshbaradaran

Member Board Of Directors

Don Mccaughey

Member Board Of Directors

Alun Rees

Senior Director Cmc

Mark Bazett

Senior Director Of Preclinical Development